跳至主要内容
临床试验/NCT04079114
NCT04079114终止不适用

Post Market Clinical Follow-Up Study of the Zimmer Stafit Acetabular System. A Multicenter, Prospective, Non-controlled Study

Zimmer Biomet0 个研究点目标入组 166 人开始时间: 2011年4月28日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Zimmer Biomet
入组人数
166
主要终点
Dislocation Rate

研究概览

简要总结

This study is a Post Market Clinical Follow up study to fulfil the post market surveillance obligations according to Medical Device Directive and European Medical Device Vigilance System (MEDDEV) 2.12-2. The data collected from this study will serve the purpose of confirming safety and performance of the Zimmer Stafit Acetabular System.

详细描述

The objective of this study is to obtain implant survival and outcome data on the Stafit Acetabular System by analysis of standard scoring systems, radiographs, and adverse event records.

Data will be used to monitor pain, mobility, dislocation rate and implant survival, and to confirm the long-term safety and performance of the Stafit Acetabular System in primary total hip arthroplasty.

The study design is a multi-center, prospective, non-controlled, consecutive cohort post market clinical follow-up study, involving orthopedic surgeons skilled in total hip arthroplasty procedures and experienced with the Stafit Acetabular System.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females
  • Patients suffering from severe hip pain and disability requiring a primary total hip arthroplasty.
  • 18 years minimum
  • Patients able to participate in a follow-up program based upon physical examination and medical history
  • Patients who have provided written informed consent by signing the Patient Informed Consent Form.

排除标准

  • Patients who are unwilling or unable to give informed consent, or to comply with the follow-up program
  • Known pregnancy
  • Revision hip arthroplasty

结局指标

主要结局

Dislocation Rate

时间窗: 2 years

Assessed by counting the number of implant dislocations

Implant Survival

时间窗: 3 years postoperatively, due to early study termination

Represents the implants that survived by counting the number of implants revised.

次要结局

  • Evaluation of Pain and Functional Performance Determined by the Harris Hip Score(3 years postoperatively, due to early study termination)
  • Confirmation of Safety Based on Complications(3 years postoperatively, due to early study termination)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

相似试验